title: Intestinal Behçet's disease with an esophageal ulcer.
authors.affiliation: Department of Gastroenterology, Kyoto Second Red Cross Hospital, Kyoto, Japan.
authors.forename: Hideaki
authors.initials: H
authors.lastname: Kawabata
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Miyata
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Kawaguchi
authors.forename: Moose
authors.initials: M
authors.lastname: Ueda
authors.forename: Koji
authors.initials: K
authors.lastname: Uno
authors.forename: Kiyohito
authors.initials: K
authors.lastname: Tanaka
authors.forename: Eisai
authors.initials: E
authors.lastname: Cho
authors.forename: Kenjiro
authors.initials: K
authors.lastname: Yasuda
authors.forename: Masatsugu
authors.initials: M
authors.lastname: Nakajima
mesh_terms: D000328:Adult; D001528:Behcet Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D001707:Biopsy, Needle; D003113:Colonoscopy; D004935:Esophageal Diseases / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D004945:Esophagoscopy; D005500:Follow-Up Studies; D006801:Humans; D007077:Ileal Diseases / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014456:Ulcer / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy
chemical_list: D011239:Prednisolone